Original language | English (US) |
---|---|
Pages (from-to) | 103-104 |
Number of pages | 2 |
Journal | Seminars in nuclear medicine |
Volume | 38 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Seminars in nuclear medicine, Vol. 38, No. 2, 03.2008, p. 103-104.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Letter from the Editors
AU - Freeman, Leonard M.
AU - Blaufox, M. Donald
N1 - Funding Information: An additional feature of this issue is a supplemental section also on radiation therapy but, in this case, nuclear medicine radiation therapy. It has been sponsored and supported by the International Atomic Energy Agency (IAEA). The project that is described in great detail was directed at the treatment of liver cancer. The publication of this supplemental section owes its origin to Dr. A. Padhy, who originally approached the editors about the possibility of a supplement. This concept has been strongly supported by Dr. M. Dondi, the head of the Nuclear Medicine Section of the Division of Human Health of the IAEA. The liver cancer project has been a very ambitious program of the International Atomic Energy Agency in the field of human health. It was performed under their program to link research and development with postgraduate education and training in developing countries. The resultant product of this research is 188 Re lipiodol. Its established safety and efficacy offers the possibility of clinical application in patients. It is particularly noteworthy that the program was developed with the collaboration of 7 researchers from several developing countries. Although it is a lesser but significant problem in the United States, liver cancer is a very great problem in many developing countries, and the potential of introducing a therapeutic modality that can be successful provides hope for many of these unfortunate patients. In addition to the contributors from developing countries, there has been considerable collaboration with other investigators including Drs. Divgi and Zanzonico who played an important role in the program. This supplemental section should be of interest to all readers in understanding liver cancer, understanding the potential role of nuclear medicine and its treatment, and providing some insight into the role of the IAEA in promoting education, medical research and technology transfer among nuclear medicine communities in developing countries. Copyright: Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2008/3
Y1 - 2008/3
UR - http://www.scopus.com/inward/record.url?scp=38549156319&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38549156319&partnerID=8YFLogxK
U2 - 10.1053/j.semnuclmed.2007.11.004
DO - 10.1053/j.semnuclmed.2007.11.004
M3 - Editorial
AN - SCOPUS:38549156319
SN - 0001-2998
VL - 38
SP - 103
EP - 104
JO - Seminars in Nuclear Medicine
JF - Seminars in Nuclear Medicine
IS - 2
ER -